Chakraborty Sourabh Shankar, Sahu Ranjit Kumar, Midya Manojit, Malhotra Anjana, Goel Akhil Dhanesh, Pundhir Ashish, Acharya Sudeshna
Department of Plastic Surgery, South Eastern Railway Central Hospital, Kolkata, West Bengal, India.
Department of Burns & Plastic Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Indian J Plast Surg. 2022 Dec 22;56(3):260-266. doi: 10.1055/s-0042-1759726. eCollection 2023 Jun.
Defining cut-off values of flap glucose levels in diagnosing free flap vascular compromise, without taking patients' glucose levels into account, does not hold good in all circumstances, especially in cases of high fluctuations in patients' capillary blood glucose and in diabetic patients. The aim of our study was to establish the role of capillary blood glucose measurements of the flap in relation to patients' fingertip, as an objective tool for postoperative free flap monitoring. A total of 76 free flaps underwent postoperative monitoring with reference test (clinical parameters) and simultaneously with our index test (difference between capillary blood glucose of free flap and the patient), in non-diabetic and diabetic patients. Patients' demography and flap characteristics were also recorded. An ROC curve was plotted to determine diagnostic accuracy and cut-offs of the index test in diagnosing free flap vascular compromise. Our Index test has a cut-off value of 24.5 mg/dL with 68.75% sensitivity and 93% specificity, with an accuracy of 91.54%. The difference between capillary blood glucose of free flap and the patient is simple, feasible, and inexpensive, and can be done by any health care professional and does not require any specialized facilities or training. It has an excellent diagnostic accuracy to detect impending free flap vascular compromise, especially in non-diabetics. Although in diabetics, this test becomes less accurate. Being an observer-independent objective test, the difference in capillary blood glucose of patient and flap measurement can be used as a highly reliable tool for postoperative free flap monitoring.
在诊断游离皮瓣血管危象时,不考虑患者血糖水平而定义皮瓣血糖水平的临界值,在所有情况下都不适用,尤其是在患者毛细血管血糖波动较大以及糖尿病患者中。我们研究的目的是确定皮瓣毛细血管血糖测量相对于患者指尖血糖测量的作用,作为术后游离皮瓣监测的一种客观工具。
共有76例游离皮瓣在非糖尿病和糖尿病患者中接受了术后监测,同时采用参考测试(临床参数)和我们的指标测试(游离皮瓣与患者毛细血管血糖的差值)。还记录了患者的人口统计学信息和皮瓣特征。绘制ROC曲线以确定指标测试在诊断游离皮瓣血管危象中的诊断准确性和临界值。
我们的指标测试临界值为24.5mg/dL,灵敏度为68.75%,特异性为93%,准确性为91.54%。
游离皮瓣与患者毛细血管血糖的差值简单、可行且成本低廉,任何医护人员都可进行,无需任何专门设施或培训。它在检测即将发生的游离皮瓣血管危象方面具有出色的诊断准确性,尤其是在非糖尿病患者中。尽管在糖尿病患者中,该测试的准确性会降低。作为一种独立于观察者的客观测试,患者与皮瓣毛细血管血糖测量的差值可作为术后游离皮瓣监测的高度可靠工具。